Health ❯Healthcare ❯Clinical Trials

Phase II Trials

HLX-1502 Drug Efficacy Weight Loss Drugs Weight Management

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

Amgen's Weight-Loss Drug Shows Promise but Faces Investor Skepticism

Pfizer's New Drug Shows Promise in Combatting Cancer-Related Weight Loss